Angelo Gordon & Co’s Biote Corp BTMD Stock Holding History

Angelo Gordon & Co’s Portfolio BTMD Stock Details BTMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-75,000	Closed	-$741K	–	252
2022 Q1	$741K	Buy	+75,000	New	+$738K	0.08%	132

Other funds holding BTMD

Cohanzick Management Pleasantville, New York $231K AUM 3.17% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

PCM

Prelude Capital Management New York $1.31B AUM 62.01% 1-Year Est. Return

Diametric Capital Boston, Massachusetts $385M AUM 31.69% 1-Year Est. Return

CAC

Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Creative Planning Overland Park, Kansas $147B AUM 18.73% 1-Year Est. Return

PCM

Penserra Capital Management Orinda, California $8.52B AUM 37.76% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

TPMI

Tilden Park Management I New York $5.38M AUM 28.49% 1-Year Est. Return

Angelo Gordon & Co's BTMD Position: Q2 2022 in Review

Angelo Gordon & Co sold out of Biote Corp (BTMD) in Q2 2022, closing a stake of 75,000 shares — an estimated $741K sold.

Angelo Gordon & Co first reported a position in BTMD in Q1 2022 and held it in 1 quarter. The position peaked at $741K in Q1 2022. 12 funds tracked by Wall St. Rank hold BTMD as of Q2 2022.

Angelo Gordon & Co reported no remaining Biote Corp position as of Q2 2022 after selling out during the quarter.
Angelo Gordon & Co sold 75,000 Biote Corp shares in Q2 2022, an estimated $741K.
Angelo Gordon & Co first reported a position in Biote Corp in Q1 2022 and held it in 1 quarter.
Angelo Gordon & Co's Biote Corp position peaked at $741K in Q1 2022.
12 funds tracked by Wall St. Rank held Biote Corp as of Q2 2022.

Based on Angelo Gordon & Co's 13F filing for Q2 2022, filed 15 Aug 2022.